In our experience, the overall detection rate for PET/MRI was 74% in 70 patients with an early biochemical PCa recurrence and a median PSA level of 0.49 ng/mL (range 0.1–5.60 ng/mL). Here, KLK3 is linked to posterior cortical atrophy.